Complete Blood Count (CBC) Analyzers and Reagents

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W40M MRCO EAST

Contract Value

Not provided

Codes & Classification
Solicitation Number

W81K0426QA025

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

NONE

Place of Performance

Fort Bragg, North Carolina, UNITED STATES

SourceSAM
Documents5
The Department of the Army, through the W40M MRCO EAST contracting office, has issued a solicitation (W81K0426QA025) for the provision of Complete Blood Count (CBC) analyzers and associated reagents, equipment, and services. This procurement is intended to support the diagnostic and laboratory needs of Womack Army Medical Center (WAMC) and two affiliated clinics—Clark Health Clinic and Robinson Health Clinic—located at Fort Bragg, North Carolina. The scope of this requirement encompasses the supply, delivery, installation, and ongoing support of advanced CBC analytical systems and related accessories. Specifically, the contractor will be responsible for furnishing two automated CBC analyzers, one slide maker/stainer, and one digital cell imager for WAMC. Additionally, two identical automated CBC analyzers are to be delivered and installed—one each at Clark Health Clinic and Robinson Health Clinic. All analyzers must operate on a Cost Per Reportable Result (CPRR) basis, ensuring that the government pays only for valid, reportable test results as outlined in the Statement of Work (SOW). A recent amendment to the solicitation has introduced several changes to the SOW, including the addition of a requirement (Section 4.24) that the CBC analyzer at WAMC must be FDA-approved for performing automated cell counts on various body fluids (cerebrospinal, synovial, pleural, and peritoneal), specifically for white and red blood cell counts. Other modifications include the removal and revision of certain SOW sections, as detailed in Attachment 1 (1449 AMENDED - W81K0426QA025). Contractors are advised to review all attachments for comprehensive requirements, line-item details, and applicable provisions and clauses. The contract will be structured as a Firm-Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) agreement, with a delivery period spanning from April 1, 2026, through March 31, 2031. The validation period for the equipment is set for March 1–31, 2026, prior to the commencement of the delivery period. The contractor will be expected to provide all necessary non-personal services, including reagents, testing systems, equipment, personnel, transportation, materials, supervision, equipment maintenance, and training. This opportunity is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with a size standard of 1,250 employees, and Product Service Code (PSC) 6550 (In vitro diagnostic substances, reagents, test kits and sets). The solicitation is issued as Full and Open, with no set-aside restrictions, inviting participation from all qualified vendors. The place of performance for this contract is Fort Bragg, North Carolina, encompassing WAMC and the two specified clinics. The contracting activity is managed by W40M MRCO EAST, a federal office under the Department of Defense, Department of the Army. Interested contractors should direct all inquiries to the designated points of contact: Victoria Manigault ([email protected]) and Anush Collins ([email protected]). The solicitation remains active, with responses due by February 20, 2026, at 12:00 PM EST. All terms and conditions, aside from those amended in the latest SOW update, remain unchanged. This procurement represents a significant opportunity for vendors specializing in in-vitro diagnostic equipment and services, particularly those with experience in providing comprehensive, turnkey laboratory solutions to federal healthcare facilities. Contractors should ensure their proposed solutions meet all technical, regulatory, and operational requirements as detailed in the solicitation and its attachments.